DK1267831T3 - Hidtil ukendt selvemulgerende system til lægemiddelindgift - Google Patents

Hidtil ukendt selvemulgerende system til lægemiddelindgift

Info

Publication number
DK1267831T3
DK1267831T3 DK01910304T DK01910304T DK1267831T3 DK 1267831 T3 DK1267831 T3 DK 1267831T3 DK 01910304 T DK01910304 T DK 01910304T DK 01910304 T DK01910304 T DK 01910304T DK 1267831 T3 DK1267831 T3 DK 1267831T3
Authority
DK
Denmark
Prior art keywords
drug administration
emulsifying system
hitherto unknown
optionally
unknown self
Prior art date
Application number
DK01910304T
Other languages
English (en)
Inventor
Christina Holmberg
Britta Siekmann
Original Assignee
Nicox Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicox Sa filed Critical Nicox Sa
Application granted granted Critical
Publication of DK1267831T3 publication Critical patent/DK1267831T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK01910304T 2000-03-08 2001-03-06 Hidtil ukendt selvemulgerende system til lægemiddelindgift DK1267831T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0000774A SE0000774D0 (sv) 2000-03-08 2000-03-08 New formulation

Publications (1)

Publication Number Publication Date
DK1267831T3 true DK1267831T3 (da) 2006-03-20

Family

ID=20278740

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01910304T DK1267831T3 (da) 2000-03-08 2001-03-06 Hidtil ukendt selvemulgerende system til lægemiddelindgift

Country Status (29)

Country Link
US (2) US7736666B2 (da)
EP (1) EP1267831B1 (da)
JP (1) JP4656479B2 (da)
KR (1) KR100771318B1 (da)
CN (1) CN1283229C (da)
AR (1) AR027554A1 (da)
AT (1) ATE311173T1 (da)
AU (2) AU3787501A (da)
BR (1) BR0109012B1 (da)
CA (1) CA2401857A1 (da)
CZ (1) CZ303524B6 (da)
DE (1) DE60115402T2 (da)
DK (1) DK1267831T3 (da)
EE (1) EE200200483A (da)
ES (1) ES2253354T3 (da)
HK (1) HK1053795A1 (da)
HU (1) HU229103B1 (da)
IL (1) IL151380A0 (da)
IS (1) IS6538A (da)
MX (1) MXPA02008658A (da)
MY (1) MY137749A (da)
NO (1) NO331921B1 (da)
RU (1) RU2275908C2 (da)
SE (1) SE0000774D0 (da)
SI (1) SI1267831T1 (da)
SK (1) SK285749B6 (da)
UA (1) UA76098C2 (da)
WO (1) WO2001066087A1 (da)
ZA (1) ZA200207109B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9600070D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
SE0000773D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
IT1319202B1 (it) 2000-10-12 2003-09-26 Nicox Sa Farmaci per le malattie a base infiammatoria.
SE0102993D0 (sv) * 2001-09-07 2001-09-07 Astrazeneca Ab New self emulsifying drug delivery system
ITMI20021392A1 (it) * 2002-06-25 2003-12-29 Nicox Sa Forme farmaceutiche per la somministrazione orale di farmaci liquidi a temperatura ambiente dotate di migliore biodisponibilita'
AU2003900887A0 (en) * 2003-02-27 2003-03-13 Novasel Australia Pty Ltd Poloxamer emulsion preparations
US8802116B2 (en) 2003-02-27 2014-08-12 Novasel Australia Pty. Ltd. Poloxamer emulsion preparations
DE10353937A1 (de) * 2003-11-18 2005-06-30 Fresenius Medical Care Deutschland Gmbh Vorrichtung zur Übertragung einer Referenzflüssigkeit in ein Messgerät, Messgerät mit einer solchen Vorrichtung und Verfahren zur Übertragung einer Referenzflüssigkeit in ein Messgerät
GB0402679D0 (en) * 2004-02-06 2004-03-10 Novartis Ag Organic compounds
KR20070008720A (ko) * 2004-05-06 2007-01-17 에미스페어 테크놀로지스, 인코포레이티드 습윤 헤파린의 고체 투여형
NZ551196A (en) 2004-05-14 2010-08-27 Emisphere Tech Inc Compounds and compositions for delivering active agents
KR100654617B1 (ko) * 2004-09-23 2006-12-08 정해현 스틱이 내장된 커피믹스 팩과 커피믹스 박스
SI1906938T1 (sl) * 2005-07-26 2011-02-28 Nicox Sa Farmacevtska formulacija nitrooksiderivatov od NSAID
DK2268160T3 (da) 2008-03-20 2013-01-07 Virun Inc Emulsioner omfattende et PEG-derivat af tokoferol
CA2715018C (en) 2008-03-20 2012-11-13 Virun, Inc. Vitamin e derivatives and their uses
EP2488022B1 (en) 2009-10-16 2018-01-10 Mochida Pharmaceutical Co., Ltd. Compositions
WO2011162802A1 (en) 2010-06-21 2011-12-29 Virun, Inc. Compositions containing non-polar compounds
US9968557B1 (en) 2011-02-09 2018-05-15 Florida A&M University Method of preparing modified multilayered microstructures with enhanced oral bioavailability
KR20240076240A (ko) * 2022-11-23 2024-05-30 (주) 바이오인프라생명과학 더블 에멀젼 구조의 초음파 감응형 약물전달체를 생성하는 방법

Family Cites Families (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
CY1398A (en) 1981-09-04 1987-12-18 Glaxo Group Ltd Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
JPS59227870A (ja) 1983-06-07 1984-12-21 Yamanouchi Pharmaceut Co Ltd 新規２−グアニジノチアゾリン誘導体ならびにその製造法
US4554276A (en) 1983-10-03 1985-11-19 Pfizer Inc. 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
US4522826A (en) 1984-02-08 1985-06-11 Richardson-Vicks Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4552899A (en) 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
IL75400A (en) 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
JPS6150978A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
AU4640985A (en) 1984-08-31 1986-03-06 Nippon Chemiphar Co. Ltd. Benzimidazole derivatives
US4766117A (en) 1984-10-11 1988-08-23 Pfizer Inc. Antiinflammatory compositions and methods
US4676984A (en) 1985-08-14 1987-06-30 American Home Products Corp. Rehydratable antacid composition
US4704278A (en) 1984-10-17 1987-11-03 American Home Products Corp (Del) Fluidized magaldrate suspension
US5037815A (en) 1986-03-04 1991-08-06 Bristol-Myers Squibb Co. Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 - and H2 -receptor blockers
US5043358A (en) 1986-03-04 1991-08-27 Bristol-Myers Squibb Company Gastroprotective process
US4757060A (en) 1986-03-04 1988-07-12 Bristol-Myers Company Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 and H2, receptor blockers
US4965065A (en) 1986-04-29 1990-10-23 Bristol-Myers Squibb Company Gastroprotective process and compositions
GB2189698A (en) 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
US5260333A (en) 1986-08-08 1993-11-09 Bristol Myers Squibb Company Effect of a combination of a terbutaline, diphenhydramine and ranitidine composition on gastrointestinal injury produced by nonsteroidal anti-inflammatory compositions
GB8630273D0 (en) 1986-12-18 1987-01-28 Til Medical Ltd Pharmaceutical delivery systems
EP0320550A1 (en) 1987-12-18 1989-06-21 Bristol-Myers Company Non steroidal anti-inflammatory drug composition containing H1 blockers, H2 blockers, beta adrenergic agonists or combinations thereof and an alkalizing agent
SE8804629D0 (sv) 1988-12-22 1988-12-22 Ab Haessle New therapeutically active compounds
US5204118A (en) 1989-11-02 1993-04-20 Mcneil-Ppc, Inc. Pharmaceutical compositions and methods for treating the symptoms of overindulgence
NZ235877A (en) 1989-11-02 1992-09-25 Mcneil Ppc Inc Composition comprising acetaminophen or nsaid and an h 1 or h 2 receptor blocker and/or proton pump inhibitor for treating overindulgence
WO1992015332A1 (en) 1991-03-04 1992-09-17 Warner-Lambert Company Novel salts/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms
DE4131678A1 (de) 1991-04-13 1992-10-15 Beiersdorf Ag Stabile multiple emulsionen
EP0550083B1 (en) 1991-12-06 1999-03-24 Glaxo Group Limited Medicaments for treating inflammatory conditions or for analgesia containing a NSAID and ranitidine bismuth citrate
AU3247593A (en) 1991-12-20 1993-07-28 Warner-Lambert Company Therapeutic combinations useful in the treatment of gastroesophageal reflux disease
US5294433A (en) 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis
IT1256345B (it) 1992-08-20 1995-12-01 Esteri nitrici di derivati dell'acido 2-(2,6-di-alo-fenilammino) fenilacetico e procedimento per la loro preparazione
EP0663839A4 (en) 1992-09-29 1998-06-03 Merck & Co Inc COMBINATIONS OF IBUPROFEN WITH A H2 ANTAGONIST.
IT1256450B (it) 1992-11-26 1995-12-05 Soldato Piero Del Esteri nitrici con attivita' farmacologica e procedimento per la loro preparazione
US5686105A (en) 1993-10-19 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
CH686761A5 (de) * 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
SE9301830D0 (sv) 1993-05-28 1993-05-28 Ab Astra New compounds
DK66493D0 (da) 1993-06-08 1993-06-08 Ferring A S Praeparater, isaer til brug ved behandling af inflammatoriske tarmsygdomme eller til at opnaa forbedret saarheling
SE9302396D0 (sv) 1993-07-09 1993-07-09 Ab Astra A novel compound form
US6312704B1 (en) * 1993-09-30 2001-11-06 Gattefosse, S.A. Orally administrable composition capable of providing enhanced bioavailability when ingested
US6054136A (en) 1993-09-30 2000-04-25 Gattefosse S.A. Orally administrable composition capable of providing enhanced bioavailability when ingested
FR2710535B1 (fr) * 1993-09-30 1995-11-24 Gattefosse Ets Sa Composition à usage pharmaceutique ou cosmétique apte à former une microémulsion.
AU678063B2 (en) * 1993-10-06 1997-05-15 Nicox S.A. Nitric esters having anti-inflammatory and/or analgesic activity and process for their preparation
EP0724441A1 (en) 1993-10-19 1996-08-07 The Procter & Gamble Company Picosulphate dosage form
US5514663A (en) 1993-10-19 1996-05-07 The Procter & Gamble Company Senna dosage form
US6025395A (en) 1994-04-15 2000-02-15 Duke University Method of preventing or delaying the onset and progression of Alzheimer's disease and related disorders
US5643960A (en) 1994-04-15 1997-07-01 Duke University Method of delaying onset of alzheimer's disease symptoms
DK0759899T3 (da) 1994-05-10 1999-12-20 Nicox Sa Nitroforbindelser og sammensætninger deraf med antiinflammatoriske, analgetiske og antitrombotiske aktiviteter
DK0723436T3 (da) 1994-07-08 2001-11-26 Astrazeneca Ab Tabletteret flerenhedsdoseringsform
SE9500478D0 (sv) 1995-02-09 1995-02-09 Astra Ab New pharmaceutical formulation and process
AU692255B2 (en) * 1995-04-24 1998-06-04 Yissum Research Development Company Of The Hebrew University Of Jerusalem Self-emulsifiable formulation producing an oil-in-water emulsion
US5955451A (en) 1995-05-12 1999-09-21 The University Of Texas System Board Of Regents Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein
EP0760237A1 (en) * 1995-08-30 1997-03-05 Cipla Limited Oil-in-water microemulsions
SE9600070D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
US6231888B1 (en) 1996-01-18 2001-05-15 Perio Products Ltd. Local delivery of non steroidal anti inflammatory drugs (NSAIDS) to the colon as a treatment for colonic polyps
CA2271799A1 (en) 1996-11-22 1998-05-28 The Procter & Gamble Company Compositions for the treatment of gastrointestinal disorders containing bismuth, and nsaid and one or more antimicrobials
US6160020A (en) 1996-12-20 2000-12-12 Mcneill-Ppc, Inc. Alkali metal and alkaline-earth metal salts of acetaminophen
SE510666C2 (sv) 1996-12-20 1999-06-14 Astra Ab Nya Kristallmodifikationer
SE510643C2 (sv) 1997-06-27 1999-06-14 Astra Ab Termodynamiskt stabil omeprazol natrium form B
KR100509131B1 (ko) * 1997-07-29 2005-08-18 파마시아 앤드 업존 캄파니 엘엘씨 산성 친지성 화합물의, 자가유화 제제 형태의 제약 조성물
EP1017370B1 (en) 1997-09-11 2003-10-29 Nycomed Danmark ApS MODIFIED RELEASE MULTIPLE-UNITS COMPOSITIONS OF NON-STEROID ANTI-INFLAMMATORY DRUG SUBSTANCES (NSAIDs)
CA2307887A1 (en) 1997-10-31 1999-05-14 Monsanto Company Gellan gum tablet coating
JP2002501897A (ja) 1998-01-30 2002-01-22 セプラコール， インク． Ｒ−ランソプラゾール組成物及び方法
WO1999038512A1 (en) 1998-01-30 1999-08-05 Sepracor Inc. S-lansoprazole compositions and methods
JP2002513750A (ja) * 1998-05-07 2002-05-14 エラン コーポレーシヨン ピーエルシー 溶媒／助溶剤を含まないマイクロエマルジョン及びエマルジョンプレ濃縮物のドラッグデリバリーシステム
EP0984012A3 (en) 1998-08-31 2001-01-10 Pfizer Products Inc. Nitric oxide releasing oxindole prodrugs with analgesic and anti-inflammatory properties
JP5068401B2 (ja) 1998-09-28 2012-11-07 カプスゲル・ベルギウム・ナムローゼ・フェンノートシャップ Ｈｐｍｃカプセルを使用する腸及び結腸への送達
US6485747B1 (en) 1998-10-30 2002-11-26 Monsanto Company Coated active tablet(s)
IL143580A0 (en) * 1998-12-11 2002-04-21 Pharmasolutions Inc Pharmaceutical compositions containing lipophilic drugs and methods for the preparation thereof
US6635281B2 (en) * 1998-12-23 2003-10-21 Alza Corporation Gastric retaining oral liquid dosage form
US6267985B1 (en) 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
ES2234582T3 (es) 1999-03-31 2005-07-01 PHARMACIA & UPJOHN COMPANY LLC Emulsiones farmaceuticas para inhibidores de proteasas retrovirales.
WO2000071122A1 (en) 1999-05-20 2000-11-30 Par Pharmaceutical, Inc. Stabilized composition based on pyridinyl-sulfinyl-benzimidazoles and process
TWI243672B (en) * 1999-06-01 2005-11-21 Astrazeneca Ab New use of compounds as antibacterial agents
US6126816A (en) * 1999-07-14 2000-10-03 Ruiz, Jr.; Reuben F. Wastewater treatment device
US20020102301A1 (en) * 2000-01-13 2002-08-01 Joseph Schwarz Pharmaceutical solid self-emulsifying composition for sustained delivery of biologically active compounds and the process for preparation thereof
US6787164B2 (en) 2000-02-23 2004-09-07 Bioselect Innovations, Inc. Composition and method for treating the effects of diseases and maladies
SE0000773D0 (sv) 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
US20020044962A1 (en) 2000-06-06 2002-04-18 Cherukuri S. Rao Encapsulation products for controlled or extended release
SE0002476D0 (sv) 2000-06-30 2000-06-30 Astrazeneca Ab New compounds
US6544556B1 (en) 2000-09-11 2003-04-08 Andrx Corporation Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
US20020045184A1 (en) 2000-10-02 2002-04-18 Chih-Ming Chen Packaging system
FR2818905A1 (fr) * 2000-12-28 2002-07-05 Cll Pharma Compositions pharmaceutiques colloidales micellaires renfermant un principe actif lipophile
AR036354A1 (es) 2001-08-31 2004-09-01 Takeda Chemical Industries Ltd Preparacion solida
US7467633B2 (en) * 2005-03-10 2008-12-23 Huntsman Petrochemical Corporation Enhanced solubilization using extended chain surfactants

Also Published As

Publication number Publication date
CZ303524B6 (cs) 2012-11-14
SE0000774D0 (sv) 2000-03-08
NO331921B1 (no) 2012-04-30
SK285749B6 (sk) 2007-07-06
IL151380A0 (en) 2003-04-10
EE200200483A (et) 2004-02-16
MY137749A (en) 2009-03-31
MXPA02008658A (es) 2003-02-24
CN1416336A (zh) 2003-05-07
ES2253354T3 (es) 2006-06-01
US20030077303A1 (en) 2003-04-24
CN1283229C (zh) 2006-11-08
WO2001066087A1 (en) 2001-09-13
IS6538A (is) 2002-09-03
SI1267831T1 (sl) 2006-04-30
DE60115402D1 (de) 2006-01-05
HK1053795A1 (en) 2003-11-07
KR100771318B1 (ko) 2007-10-29
BR0109012B1 (pt) 2014-08-26
ATE311173T1 (de) 2005-12-15
SK12582002A3 (sk) 2003-04-01
AU3787501A (en) 2001-09-17
HUP0300539A2 (hu) 2003-07-28
EP1267831A1 (en) 2003-01-02
NO20024194L (no) 2002-09-03
RU2002122745A (ru) 2004-03-20
ZA200207109B (en) 2003-12-04
HU229103B1 (en) 2013-07-29
UA76098C2 (en) 2006-07-17
RU2275908C2 (ru) 2006-05-10
EP1267831B1 (en) 2005-11-30
KR20030011788A (ko) 2003-02-11
JP4656479B2 (ja) 2011-03-23
CZ20023006A3 (cs) 2003-02-12
AU2001237875B2 (en) 2005-05-12
HUP0300539A3 (en) 2003-09-29
CA2401857A1 (en) 2001-09-13
JP2003525893A (ja) 2003-09-02
US20100266683A1 (en) 2010-10-21
BR0109012A (pt) 2003-06-03
AR027554A1 (es) 2003-04-02
DE60115402T2 (de) 2006-08-03
US7736666B2 (en) 2010-06-15
NO20024194D0 (no) 2002-09-03
PL358617A1 (en) 2004-08-09

Similar Documents

Publication Publication Date Title
DK1267831T3 (da) Hidtil ukendt selvemulgerende system til lægemiddelindgift
PT1267832E (pt) Sistema auto-emulsionante de libertacao de farmaco
KR870002835A (ko) 이온화성 소수성약제의 약제학적 제조방법
DK1320356T4 (da) Fremstilling af vitaminemulsioner og koncentrater deraf
ATE270544T1 (de) Halbfeste arzneizubereitung enthaltend isotretinoin
MA28748B1 (fr) Applications galeniques de melanges auto-emulsionnants d'excipients lipidiques
BRPI0513051A (pt) combinação de inibidores de transcriptase reversa e de protease anti-hiv
SE0102993D0 (sv) New self emulsifying drug delivery system
NO20034139L (no) Faste oralt dispergerbare farmasöytiske formuleringer
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
BR0112860A (pt) Dispositivo para coleta de lìquido seminal animal
DE60101370D1 (de) Pharmazeutische zusammensetzungen, die terbinafin enthalten
DK1089710T3 (da) Injicerbare farmaceutiske formuleringer af partricinderivater
EA200600009A2 (ru) Фармацевтические композиции, содержащие активные соединения витамина d
TH100976B (th) ระบบนำส่งยาแบบอีมัลชิฟายตัวเองชนิดใหม่
AR012019A1 (es) Compuesto de criptoficina y su uso para preparar un medicamento
TH77896A (th) สารประกอบชนิดใหม่
UA34406A (uk) Засіб для лікування розсіяного склерозу, спосіб лікування з його використанням та фармацевтична упаковка